Success in leadership and entrepreneurship is often attributed to a balance of hard and soft skills. But there’s another factor that might be overlooked, and that’s the role that intrinsic motivation plays. In medtech, for example, we see company founders routinely ascribe their success to a deep desire to help patients, rather than just a drive for monetary gain.
To effectively introduce a new product to market and ensure it is widely adopted, medtech companies must consider the many facets of their go-to-market strategy from the earliest days of product development.
This was the message of the Fogarty Institute’s third-annual educational workshop focused on commercialization. The three-part seminar series, being presented virtually to adhere to COVID restrictions,
“I don’t believe in the concept of the ‘lone genius’ that journalists like to highlight when writing about the success of a company – it’s really the teams that win.”
This year’s 21stAnnual Thomas J. Fogarty, MD, Lecture held at Stanford University, featured Brook Byers, founding partner of Kleiner Perkins.
Few seminar topics engage a startup audience as wholly as intellectual property, given that it’s viewed as one of the most critical components to success. Not only does it protect a company and allow it to compete among larger players, but it raises a startup’s profile among investors. In fact, 85 percent of medical device VCs say they view patents as a critical factor for funding consideration.
From rugged outwear to groundbreaking medical devices, W. L. Gore & Associates, a diversified material science company, serves virtually every industry you can think of.
That creativity of application can only be built by one thing – a focus on innovation.
The Fogarty Institute has long enjoyed a reciprocal and collaborative relationship with El Camino Health, and over the years we have benefited from the expertise and mentoring of not only its physicians, but also its executive team.
Recently, Jim Griffith, who joined El Camino Hospital as chief operating officer in 2018,
One of the most strategically important topics for a startup is commercialization – the point when a company transitions from research focus to generating revenue, scaling the organization, and potentially driving toward an exit. As part of its educational series, the Fogarty Institute recently hosted an impressive panel who offered their thoughts on managing this important phase of a company’s lifecycle.
A patent attorney and inventor who also has extensive experience successfully founding companies, Earl ”Eb” Bright has been an invaluable player in advancing the medical technology industry.
In addition to his role as president and general counsel of ExploraMed, he has served on the executive team of many of its startup companies,
Every now and then you meet someone who deeply inspires you to strive to be the best individual and leader you can be – and who shows you the value and role of soft skills, like grit, creativity and communication, to not only survive the daily challenges we all face, but to thrive despite them.
Virtually every business talk or news story today emphasizes the revolutionary new technological advances that will transform the job landscape. And it’s true – technologies such as artificial intelligence, robots and digital platforms are already enhancing the way we work.
But often lost in the focus on these shiny new objects, is the need for workers to nimbly adapt to new environments,